Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antipsychotic-induced extrapyramidal side effects: A systematic review and meta-analysis of observational studies
Tilahun Ali, Mekonnen Sisay, Mandaras Tariku, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0257129-e0257129
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Advantages and Limitations of Animal Schizophrenia Models
Magdalena Białoń, Agnieszka Wąsik
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5968-5968
Open Access | Times Cited: 67
The magnitude and variability of neurocognitive performance in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies
Ana Catalán, Robert A. McCutcheon, Clàudia Aymerich, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Pharmacologic treatment of delirium symptoms: A systematic review
Monika Sadlonova, Laura Duque, Diana M. Smith, et al.
General Hospital Psychiatry (2022) Vol. 79, pp. 60-75
Open Access | Times Cited: 38
The Relationship Between Antipsychotics, Cognitive Enhancers, and Major Adverse Cardiovascular/Cerebrovascular Events (MACCE) in Older Adults with Behavioral and Psychological Symptoms of Dementia
Haylie M. DeMercy, Colleen A. Brenner
Drugs & Aging (2024) Vol. 41, Iss. 10, pp. 847-858
Open Access | Times Cited: 5
MicroRNAs as potential biomarkers for diagnosis of schizophrenia and influence of antipsychotic treatment
Bridget Martinez, Philip V. Peplow
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1523-1531
Open Access | Times Cited: 11
Psychotropic drug-induced adverse drug reactions in 462,661 psychiatric inpatients in relation to age: results from a German drug surveillance program from 1993–2016
Johanna Seifert, Matthias A. Reinhard, Stefan Bleich, et al.
Annals of General Psychiatry (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Schizophrenia and Related Psychoses

(2025), pp. 1-278
Closed Access
Evaluation of Global Dystonia Rating Scale as a predictor of unfavorable outcomes among acute antipsychotics poisoned patients
Asmaa Fady Sharif, Zahraa Khalifa Sobh, Sanaa Abd El‐Fatah Abdo, et al.
Drug and Chemical Toxicology (2024) Vol. 47, Iss. 4, pp. 386-403
Closed Access | Times Cited: 3
Integrating specific and common topologies of heterogeneous graphs and pairwise attributes for drug-related side effect prediction
Ping Xuan, Meng Wang, Yong Liu, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 3
Closed Access | Times Cited: 16
Scales for Antipsychotic‐Associated Movement Disorders: Systematic Review, Critique, and Recommendations
Davide Martino, Vikram Karnik, Roongroj Bhidayasiri, et al.
Movement Disorders (2023) Vol. 38, Iss. 6, pp. 1008-1026
Closed Access | Times Cited: 9
Drug-Induced Movement Disorders
Sanjay Pandey, Yuvadee Pitakpatapee, Weerawat Saengphatrachai, et al.
Seminars in Neurology (2023) Vol. 43, Iss. 01, pp. 035-047
Closed Access | Times Cited: 8
The Janus face of antipsychotics in glial cells: Focus on glioprotection
Izaviany Schmitz, Amanda da Silva, Larissa Daniele Bobermin, et al.
Experimental Biology and Medicine (2023) Vol. 248, Iss. 22, pp. 2120-2130
Open Access | Times Cited: 8
Evaluation of the acute oral toxicity and antipsychotic activity of a dual inhibitor of PDE1B and PDE10A in rat model of schizophrenia
Mayasah Al‐Nema, Anand Gaurav, Ming Tatt Lee, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0278216-e0278216
Open Access | Times Cited: 11
Adverse drug reactions in geriatric psychiatry—retrospective cohort study of a 6-year period
Johannes Heck, Nina Noltemeyer, Martin Schulze Westhoff, et al.
Irish Journal of Medical Science (1971 -) (2023) Vol. 192, Iss. 6, pp. 2917-2927
Open Access | Times Cited: 6
Benzodiazepines and Mood Stabilizers in Schizophrenia Patients Treated with Oral versus Long-Acting Injectable Antipsychotics—An Observational Study
Ana Aliana Miron, Paula Simina Petric, Andreea Teodorescu, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 173-173
Open Access | Times Cited: 5
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic
Matthew Feldman, Sarah Marmol, Jason Margolesky
Therapeutics and Clinical Risk Management (2022) Vol. Volume 18, pp. 1129-1142
Open Access | Times Cited: 8
Valproate, risperidone, and paliperidone: A case of valproate-induced hyperammonemic encephalopathy
Kyle Wesselman, Vincent Cavaliere, Rakesh K. Goyal, et al.
Mental Health Clinician (2024) Vol. 14, Iss. 1, pp. 28-32
Open Access | Times Cited: 1
Adverse Drug Reactions Among Hospitalized Psychiatric Patients, Prevalence, Severity, Preventability, and Opportunities For Intervention
Asma Al Hindi, Sara Al Balushi, Sharifa Al Ruzaiqi, et al.
Oman Medical Journal (2024) Vol. 39, Iss. 3, pp. e631-e631
Open Access | Times Cited: 1
Graph reasoning method enhanced by relational transformers and knowledge distillation for drug-related side effect prediction
Honglei Bai, Siyuan Lu, Tiangang Zhang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109571-109571
Open Access | Times Cited: 1
Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission
João Francisco Cordeiro Pedrazzi, Danyelle S Amaral, Ana Carolina Issy, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 245, pp. 173879-173879
Closed Access | Times Cited: 1
Prevalence of spontaneous movement disorders (dyskinesia, parkinsonism, akathisia and dystonia) in never-treated patients with chronic and first-episode psychosis: a systematic review and meta-analysis
Arturas Kalniunas, Katie James, Sofia Pappa
BMJ Mental Health (2024) Vol. 27, Iss. 1, pp. e301184-e301184
Open Access | Times Cited: 1
Glia-related Acute Effects of Risperidone and Haloperidol in Hippocampal Slices and Astrocyte Cultures from Adult Wistar Rats: A Focus on Inflammatory and Trophic Factor Release
Amanda da Silva, Larissa Daniele Bobermin, Camila Leite Santos, et al.
Neurochemical Research (2024) Vol. 50, Iss. 1
Closed Access | Times Cited: 1
Dopamine partial agonists: a discrete class of antipsychotics
David Taylor, R. N. Chithiramohan, Jasdev Grewal, et al.
International Journal of Psychiatry in Clinical Practice (2022) Vol. 27, Iss. 3, pp. 272-284
Closed Access | Times Cited: 7
Prevalence and Correlates of Extrapyramidal Side Effects Among Patients with Schizophrenia Spectrum Disorders on Typical and Atypical Antipsychotics
Falmata Baba Shettima, Taiwo Lateef Sheikh, Musa Abba Wakil, et al.
Archives of Psychiatry Research (2023) Vol. 59, Iss. 2, pp. 225-240
Open Access | Times Cited: 3
Schizophrenia: The Ambiguous Mechanism behind the Disorder
Mayasah Al‐Nema, Anand Gaurav
Jordan Journal of Pharmaceutical Sciences (2022) Vol. 15, Iss. 2, pp. 239-257
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top